Giant cell myocarditis following COVID-19 successfully treated by immunosuppressive therapy

被引：3

作者：

Amiri, Afsaneh ^{[1
]}

Houshmand, Golnaz ^{[1
]}

Taghavi, Sepideh ^{[1
]}

Kamali, Monireh ^{[1
]}

Faraji, Mona ^{[1
]}

Naderi, Nasim ^{[1
]}

机构：

[1] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, Iran

来源：

CLINICAL CASE REPORTS | 2022年 / 10卷 / 08期

关键词：

COVID-19; Giant cell; myocarditis; INJURY;

D O I：

10.1002/ccr3.6196

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

It has been shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), by coronavirus disease 2019 (COVID-19), can lead to multi-organ impairment including cardiac involvement and immunological problems. Acute myocarditis is one of serious and fatal complications of COVID-19. In this case report, we present a 46-year-old lady with a history of lichen planus dermatitis who has developed a rapidly progressive heart failure after an episode of COVID-19. The pathologic examination of her endomyocardial biopsy specimens was compatible with GCM, and she was successfully treated with a combined immunosuppressive therapy regimen.

引用

页数：7

共 50 条

[1] Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine
Sung, Kevin
McCain, Julia
King, Kevin R.
Hong, Kimberly
Aisagbonhi, Omonigho
Adler, Eric D.
Urey, Marcus A.
CIRCULATION-HEART FAILURE, 2022, 15 (04) : 414 - 417
[2] Combination Immunosuppressive Therapy for Giant Cell Myocarditis
Funaki, Takashi
Saji, Mike
Murai, Tatsuya
Higuchi, Ryosuke
Nanasato, Mamoru
Isobe, Mitsuaki
INTERNAL MEDICINE, 2022, 61 (19) : 2895 - 2898
[3] Giant cell myocarditis responding to immunosuppressive therapy
Frustaci, A
Chimenti, C
Pieroni, M
Gentiloni, N
CHEST, 2000, 117 (03) : 905 - 907
[4] Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy
Dennert, Robert
Velthuis, Sebastiaan
Westermann, Dirk
Donker, Dirk
Schalla, Simon
van Suylen, Robert-Jan
Heymans, Stephane
ANTIVIRAL THERAPY, 2010, 15 (04) : 681 - 685
[5] COVID-19 "Fulminant Myocarditis" Successfully Treated With Temporary Mechanical Circulatory Support
Salamanca, Jorge
Diez-Villanueva, Pablo
Martinez, Pablo
Cecconi, Alberto
Gonzalez de Marcos, Begona
Reyes, Guillermo
Salas, Clara
Segovia, Javier
Jesus Jimenez-Borreguero, Luis
Alfonso, Fernando
JACC-CARDIOVASCULAR IMAGING, 2020, 13 (11) : 2457 - 2459
[6] Immunosuppressive Therapy for Giant-Cell Myocarditis with Nanotechnology
Okuda, Keiji
Fu, Hai Ying
Tsuchida, Shota
Yamato, Masaki
Araki, Ryo
Matsuzaki, Takashi
Hanawa, Haruo
Sakata, Yasushi
Minamino, Tetsuo
JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : S188 - S188
[7] A case of parvovirus B19-associated fulminant myocarditis in an infant successfully treated with immunosuppressive therapy
Veronese, Giacomo
Nonini, Sandra
Bottiroli, Maurizio
Annoni, Giuseppe
Izzo, Francesca
Nespoli, Luisa F.
Corato, Alessandra
Marianeschi, Stefano M.
Aresta, Francesca
Bramerio, Manuela A.
Mondino, Michele
Ammirati, Enrico
JOURNAL OF CARDIOVASCULAR MEDICINE, 2022, 23 (10) : 697 - 699
[8] Myocarditis Following COVID-19 Vaccination
Marschner, Constantin A.
Shaw, Kirsten E.
Tijmes, Felipe Sanchez
Fronza, Matteo
Khullar, Sharmila
Seidman, Michael A.
Thavendiranathan, Paaladinesh
Udell, Jacob A.
Wald, Rachel M.
Hanneman, Kate
CARDIOLOGY CLINICS, 2022, 40 (03) : 375 - 388
[9] Myocarditis Following COVID-19 Vaccination
Marschner, Constantin A.
Shaw, Kirsten E.
Tijmes, Felipe Sanchez
Fronza, Matteo
Khullar, Sharmila
Seidman, Michael A.
Thavendiranathan, Paaladinesh
Udell, Jacob A.
Wald, Rachel M.
Hanneman, Kate
HEART FAILURE CLINICS, 2023, 19 (02) : 251 - 264
[10] Cardiac sarcoidosis and giant cell myocarditis after COVID-19 infection
Bollano, Entela
Polte, Christian Lars
Mayranpaa, Mikko, I
Oldfors, Anders
Bergh, Niklas
Lehtonen, Jukka
Kandolin, Riina
ESC HEART FAILURE, 2022, 9 (06): : 4298 - 4303

← 1 2 3 4 5 →